Search

everythinglearnresearchcommunity

for

Search:↓

SHPro® improved urinary symptoms and erectile function in men and is safe.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Finasteride and dutasteride are equally effective and safe for treating BPH.

Carthamus oxyacantha may help treat BPH by inhibiting 5α-reductase.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Long-term diabetes is linked to lower prostate cancer risk.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride for hair loss has minimal impact on sexual function.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Early balding at 40 increases prostate cancer risk.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Higher PSA levels are linked to more hirsutism in women with PCOS.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.